greeksoup/ stock research
Stock research / United States / GSK / Year to 31 December 2024

GSK plc (GSK) annual results, year to 31 December 2024: revenue GBP 31,376 million, from the 20-F

GSK plc files a 20-F with the SEC once a year, in pounds sterling. In the year to 31 December 2024 it reported revenue of GBP 31,376 million ($40.1 billion at the year's average rate), up 3.5% on the year before. Its profit attributable to shareholders was GBP 2,575 million, down 47.7%, and diluted earnings per share GBP 0.62.

Revenue
GBP 31,376 million
+3.5% on the year
FY2017FY2024
Operating margin
12.8%
22.2% a year earlier
FY2017FY2024
Net income
GBP 2,575 million
-47.7% on the year
FY2017FY2024
Diluted EPS
GBP 0.62
-48.1% on the year
FY2017FY2024

this yearthe year beforeIn pounds sterling as filed. Hover a bar for its figure.

Income statement (profit and loss)

Year toDec 2023Dec 2024
Revenue30,32831,376
Cost of sales8,5659,048
Gross profit21,76322,328
Research and development6,2236,401
Selling, general and administrative9,38511,015
Operating profit6,7454,021
Finance costs792669
Profit before tax6,0643,477
Income tax756526
Profit for the year5,3082,951
Profit attributable to shareholders4,9282,575
Filing20-F20-F
GBP million, from the 20-F on the SEC's EDGAR, linked in the last row, on the IFRS tags the company filed.
Read moreA line the company does not file under the standard tag is left out rather than estimated.
Year toDec 2023Dec 2024
Diluted EPS1.200.62
Basic EPS1.220.63
Filing20-F20-F

GBP per ordinary share, as filed.

Cash flow

Year toDec 2023Dec 2024
Cash from operations6,7686,554
Purchase of property, plant and equipment1,3141,399
Free cash flow5,4545,155
Cash from investing-1,595-1,229
Cash from financing-5,641-4,726
Depreciation and amortisation2,2942,551
Buybacks0.00.0
Dividends paid2,2472,444
Filing20-F20-F

GBP million. Free cash flow is cash from operations less the purchase of property, plant and equipment, arithmetic on the two filed lines.

Balance sheet

Year toDec 2023Dec 2024
Funded by
Equity attributable to shareholders13,34713,671
Non-controlling interests-552-585
Borrowings, as filed18,01816,986
Lease liabilities1,2071,102
Other liabilities26,98528,289
Total equity and liabilities59,00559,463
Owned
Property, plant and equipment9,0209,227
Goodwill6,8116,982
Other intangible assets14,76815,515
Cash and cash equivalents2,9363,870
Trade and other receivables7,3856,836
Inventories5,4985,669
Other assets12,58711,364
Total assets59,00559,463
Filing20-F20-F

GBP million, at each fiscal year end.

Ratios on the filed lines

Year toDec 2023Dec 2024
Gross margin71.8%71.2%
Operating margin22.2%12.8%
Net margin16.2%8.2%
Free cash flow margin18.0%16.4%
Return on year-end equity36.9%18.8%
Effective tax rate12.5%15.1%
Filing20-F20-F

Arithmetic on the filed lines of the same year.

20-F for the year to 31 December 2024, filed 6 March 2026: the filing. The figures are in pounds sterling as filed.